Wellgistics Health, Inc. (WGRX) - Dilution Analysis

10-Q filing | 125.7M shares outstanding

S-3 filing: This is an S-3 filing for Wellgistics Health, Inc. detailing a shelf registration for common stock, preferred stock, and debt securities, which may be offered and sold from time to time.

8-K filing: Wellgistics Health, Inc. terminated the Settlement Agreement with Silverback Capital Inc., which contemplated the issuance of shares of the Company's common stock, and no additional shares will be issued under the agreement.

10-K filing | 104.9M shares outstanding

10-Q filing | 89.7M shares outstanding

8-K filing: Wellgistics Health, Inc. completed a public offering, selling 7,142,862 shares of common stock at $0.70 per share and warrants to purchase up to 7,142,862 shares, receiving gross proceeds of approximately $5 million. ($5.0M proceeds)

S-1/A filing: Wellgistics Health, Inc. is offering common stock, pre-funded warrants, and warrants in a combined offering.

10-Q filing | 84.1M shares outstanding

8-K filing: Stock split 1-for-50 | Outstanding: 71,860,505 → 1,437,210

10-Q filing | 71.9M shares outstanding

S-1 filing: This S-1 filing relates to the resale of up to 3,578,254 shares of common stock by Hudson Global Ventures, LLC and the potential issuance of shares under an ELOC Purchase Agreement.

8-K filing: Wellgistics MIPA was amended to convert a $1,500,000 cash payment owed to Strategix Global, LLC into 333,333 shares of the Company's common stock at the $4.50 initial public offering price. ($1.5M proceeds)

8-K filing: Wellgistics Health, Inc. entered into an equity purchase agreement with Hudson Global Ventures, LLC, potentially allowing the company to sell up to $50,000,000 in shares of common stock over approximately 24 months, and issued 152,000 shares of common stock to the investor as a commitment fee.

8-K filing: Wellgistics Health, Inc. granted an aggregate of 19,764,108 shares of restricted stock under the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan to independent directors, non-independent directors, employees, the CEO, former employees and consultants or advisers.

10-K filing | 47.3M shares outstanding

8-K filing: Wellgistics Health, Inc. entered into a consulting agreement with Draper, Inc., issuing 100,000 restricted shares of the Company's common stock to Draper for investor relations and business development services.

8-K filing: Wellgistics Health, Inc. entered into a consulting agreement with Hudson Global Ventures, LLC, issuing 52,000 shares of common stock as part of the consideration for business advisory services.

S-1/A filing: This S-1/A filing relates to a proposed offering of 900,000 shares of Common Stock with an expected price between $4.50 and $5.50 per share, with the proceeds intended for general corporate purposes.

S-1/A filing: This S-1/A filing relates to a proposed offering of Common Stock by Wellgistics Health, Inc., with the intention to list on the Nasdaq under the symbol WGRX. The company intends to use the net proceeds of the Offering for general corporate purposes.

S-1/A filing: Wellgistics Health, Inc. is offering 900,000 shares of common stock at an expected price between $4.50 and $5.50 per share. The company intends to use the net proceeds for general corporate purposes.

S-1/A filing: S-1/A filing for Wellgistics Health, Inc. offering common stock contingent upon Nasdaq listing with proceeds intended for general corporate purposes.

S-1/A filing: This is an S-1/A filing for Wellgistics Health, Inc. regarding an offering of common stock, with the intention to list on the Nasdaq under the symbol 'WGRX'.

S-1/A filing: This S-1/A filing relates to an offering of Common Stock. The company intends to list its Common Stock on Nasdaq under the symbol "WGRX."

S-1/A filing: This S-1/A filing from Danam Health, Inc. discusses a proposed offering of common stock, recent acquisitions (Wood Sage and pending Wellgistics), and associated risks.

S-1 filing: Danam Health, Inc. S-1 Filing for shares of Common Stock.